Deutsch English Français

Contact

EP0760602

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0760602

EP0760602 - USE OF FAS LIGAND TO SUPPRESS LYMPHOCYTE-MEDIATED IMMUNE RESPONSES [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 19.10.2007 Database last updated on 20.09.2024
Most recent event Tooltip	19.10.2007	No opposition filed within time limit	published on 21.11.2007 [2007/47]
Applicant(s)	For all designated states Donald Bellgrau 1435 Wazee Street, 207 Denver, Colorado 80202 / US
	For all designated states Duke Richard C. 934 South Josephine Street Denver, Colorado 80209 / US
	[2005/19]
Former [1997/11]	For all designated states University of Colorado 914 Broadway, Campus Box 51 Boulder, CO 80309 / US
Inventor(s)	01 / BELLGRAU, Donald 455 Fairfax Street Denver, CO 80220 / US
	02 / DUKE, Richard, C. 934 South Josephine Street Denver, CO 80209 / US
	[1997/11]
Representative(s)	Roques, Sarah Elizabeth, et al J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	[N/P]
Former [2005/37]	Roques, Sarah Elizabeth, et al J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB
Former [1997/11]	Goldin, Douglas Michael J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB
Application number, filing date	95921459.4	26.05.1995
	[1997/11]
	WO1995US06742
Priority number, date	US19940250478	27.05.1994 Original published format: US 250478
	US19950378507	26.01.1995 Original published format: US 378507
	[1997/11]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9532627
	Date:	07.12.1995
	Language:	EN
	[1995/52]
	Type:	A1 Application with search report
	No.:	EP0760602
	Date:	12.03.1997
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 07.12.1995 takes the place of the publication of the European patent application.
	[1997/11]
	Type:	B1 Patent specification
	No.:	EP0760602
	Date:	13.12.2006
	Language:	EN
	[2006/50]
Search report(s)	International search report - published on:	US	07.12.1995
	(Supplementary) European search report - dispatched on:	EP	22.04.1999
Classification	IPC:	C07K14/705, A01N37/18, A01N63/00, A61K38/00, A61K48/00, C07H21/04, C07K1/00, C07K16/00, C12N15/00, C07K14/52, C07K16/28	[1998/14]
	CPC:	C07K14/52 (EP,US); A61P29/00 (EP); A61P3/08 (EP); A61P37/00 (EP); A61P37/06 (EP); C07K14/70575 (EP,US); (+) A01K2217/05 (EP,US); A61K38/00 (EP,US); A61K48/00 (EP,US) (-)
	Former IPC [1997/11]	A01N37/18, A01N63/00, A61K38/00, A61K48/00, C07H21/04, C07K1/00, C07K16/00, C12N15/00
Designated contracting states	CH, GB, LI [1997/11]
Title	German:	VERWENDUNG VON FAS-LIGANDEN ZUR UNTERDRÜKUNG LYMPHOZYT-VERMITTELTER IMMUNREAKTIONEN	[1997/11]
	English:	USE OF FAS LIGAND TO SUPPRESS LYMPHOCYTE-MEDIATED IMMUNE RESPONSES	[1997/11]
	French:	UTILISATION DU LIGAND FAS COMME DEPRESSEUR DES REPONSES IMMUNITAIRES A MEDIATION LYMPHOCYTAIRE	[1997/11]
Entry into regional phase	16.12.1996	National basic fee paid
	16.12.1996	Search fee paid
	16.12.1996	Designation fee(s) paid
	16.12.1996	Examination fee paid
Examination procedure	15.12.1995	Request for preliminary examination filed International Preliminary Examining Authority: US
	16.12.1996	Examination requested [1997/11]
	05.06.2003	Despatch of a communication from the examining division (Time limit: M06)
	10.12.2003	Reply to a communication from the examining division
	17.02.2004	Despatch of a communication from the examining division (Time limit: M06)
	23.08.2004	Reply to a communication from the examining division
	10.02.2006	Communication of intention to grant the patent
	25.07.2006	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
	22.09.2006	Fee for grant paid
	22.09.2006	Fee for publishing/printing paid
Opposition(s)	14.09.2007	No opposition filed within time limit [2007/47]
Request for further processing for:	22.09.2006	Request for further processing filed
	22.09.2006	Full payment received (date of receipt of payment) Request granted
	09.10.2006	Decision despatched
Fees paid	Renewal fee
	27.05.1997	Renewal fee patent year 03
	30.05.1998	Renewal fee patent year 04
	26.05.1999	Renewal fee patent year 05
	15.05.2000	Renewal fee patent year 06
	29.05.2001	Renewal fee patent year 07
	14.05.2002	Renewal fee patent year 08
	17.11.2003	Renewal fee patent year 09
	26.05.2004	Renewal fee patent year 10
	27.05.2005	Renewal fee patent year 11
	30.05.2006	Renewal fee patent year 12
	Penalty fee
	Additional fee for renewal fee
	31.05.2003	09 M06 Fee paid on 17.11.2003
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CH	13.12.2006
	LI	13.12.2006
	[2007/30]
Documents cited:	Search	[E]WO9518819 (IMMUNEX CORP [US]) [E] 1-4,7-10,14,15 * claims; pages 15-20 *;
		[E]EP0675200 (MOCHIDA PHARM CO LTD [JP], et al) [E] 1-4,9,10 * claims *;
		[XA] - LYNCH, D.H. ET AL., "The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster", IMMUNITY, (1994), vol. 1, pages 131 - 136, XP002054754 [X] 1-4,8-10 * introduction; fig. 1; discussion; experimental procedures * [A] 7,11-15 DOI: http://dx.doi.org/10.1016/1074-7613(94)90106-6
		[A] - NAGATA, S., "Fas and Fas Ligand: A death factor and its receptor", ADV. IMMUNOL., (1994), vol. 57, pages 129 - 144, XP002097379 [A] 1-4,7-15 * chapter III, p. 130-132; chapters VII- IX, p. 135-140 *
		[PX] - MOUNTZ, J.D., "Autoimmune disease", ARTHRITIS & RHEUMATISM, (199410), vol. 37, no. 10, pages 1415 - 1420, XP002097380 [PX] 1-4,14 * fig. 1; p. 1417-1419 *
		[T] - LYNCH, D.H. ET AL., "Fas and FasL in the homeostatic regulation of immune responses", IMMUNOLOGY TODAY, (199512), vol. 16, no. 12, pages 569 - 574, XP002097381 [T] 1-4,7-15 * whole disclosure * DOI: http://dx.doi.org/10.1016/0167-5699(95)80079-4
	International search	[Y]US5219740 (MILLER A DUSTY [US], et al)
		[Y] - A. JOHNSTONE et al., "Immunochemistry in Practice", Published 1987, by BLACKWELL SCIENTIFIC PUBLICATIONS (OXFORD), pages 30-47.
		[YP] - INTERNATIONAL IMMUNOLOGY, Volume 6, No. 10, issued October 1994, TAKAHASHI et al., "Human Fas Ligand: Gene Structure, Chromosomal Location and Species Specificity", pages 1567-1574.
		[AP] - SCIENCE, Volume 267, issued 10 March 1995, NAGATA et al., "The Fas Death Factor", pages 1449-1456.
		[Y] - CELL, Volume 76, issued 25 March 1994, TAKAHASHI et al., "Generalized Lymphoproliferative Disease in Mice, Caused by a Point Mutation in the Fas Ligand", pages 969-976.
		[Y] - FASEB JOURNAL, Volume 8, No. 5, issued 18 March 1994, LEE et al., "Fas Ligand Expression on an Activated Cytotoxic T-Cell Line", page A770, Abstract 4467.
		[Y] - CELL, Volume 75, issued 17 December 1993, SUDA et al., "Molecular Cloning and Expression of the Fas Ligand, a Novel Member of the Tumor Necrosis Factor Family", pages 1169-1178.
		[Y] - JOURNAL OF EXPERIMENTAL MEDICINE, Volume 179, issued March 1994, SUDA et al., "Purification and Characterization of the Fas-ligand that Induces Apoptosis", pages 873-879.

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p